| Key Aspect | Details |
|---|---|
| Event | Union Cabinet approves Phase III of the Biomedical Research Career Programme (BRCP) |
| Date | 1 October 2025 |
| Chaired By | Prime Minister |
| Implementing Agencies | Department of Biotechnology (DBT) and Wellcome Trust (WT), UK (via India Alliance) |
| Objective | Nurture India's biomedical research capacity, promote translational innovation, and address regional imbalances in scientific infrastructure |
| Phase III Duration | 2025‑26 to 2030‑31 (grants serviced till 2037‑38) |
| Total Outlay | ₹1,500 crore (DBT: ₹1,000 crore, WT: ₹500 crore) |
| Key Focus Areas | Early‑career and intermediate research fellowships, collaborative grants, research management, regional capacity building, gender equity, and translational innovation |
| Expected Beneficiaries | Over 2,000 students and postdoctoral fellows |
| Gender Equity Target | 10-15% uplift in support for women researchers |
| Technology Readiness Target | 25-30% of collaborative programmes to reach TRL‑4 and above |
| Grant Types | Early Career Fellowships, Intermediate Fellowships, Career Development Grants, Catalytic Collaborative Grants, and Research Management Programme |
| Historical Context | BRCP launched in 2008‑09 (Phase I), Phase II began around 2018‑19 |
| Strategic Impact | Transform India into a hub of international parity in biomedical research, emphasize translational research, strengthen institutional systems, promote equity & inclusion, and foster global collaboration |
| Challenges | Timely fund release, infrastructure development in Tier‑2/3 regions, talent retention, accountability, and translating research into impact |
Workflow
Login
Contact Counsellor